ArticleInternational journal of women's health2025
Low Bone Mineral Density Is Associated with Higher Venous Thromboembolism Risk Scores in Postmenopausal Women.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous thromboembolism (VTE) and osteoporosis are both prevalent and clinically significant conditions in postmenopausal women. These disorders share common risk factors, including estrogen deficiency and age-related physiological changes. Although emerging evidence suggests a link between reduced bone mineral density (BMD) and thrombotic events, current VTE risk assessment models do not incorporate BMD. This study aimed to investigate the association between BMD and VTE risk in postmenopausal women. Methods: A total of 511 postmenopausal women hospitalized at the First Affiliated Hospital of Nanjing Medical University between January and December 2024 were enrolled. BMD was measured using dual-energy X-ray absorptiometry (DXA) and classified according to World Health Organization criteria. VTE risk was assessed using the Caprini Risk Assessment Score. Results: Patients with osteoporosis had significantly higher Caprini scores compared to those with normal BMD (6.20 ± 3.20 vs 5.40 ± 2.60; Conclusion: Lower BMD is independently associated with increased VTE risk in postmenopausal women. These findings suggest that BMD may serve as a novel biomarker for VTE risk. Incorporating BMD into existing risk assessment models and considering thromboprophylaxis for individuals with low BMD are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.